Courtesy of Prof. Richard FurmanBad blood | Researchers at Weill Cornell recently completed a clinical trial for Idelalisib, a new drug that kills Chronic Lymphocytic Leukemia cells, shown in dark red among blood cells.
Read More
Courtesy of Prof. Richard FurmanBad blood | Researchers at Weill Cornell recently completed a clinical trial for Idelalisib, a new drug that kills Chronic Lymphocytic Leukemia cells, shown in dark red among blood cells.